Know Cancer

forgot password

Phase 2
18 Years
Not Enrolling
Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Thank you

Trial Information

Other specific inclusion/exclusion criteria may apply. In order to determine eligibility,
further examination by the investigator is necessary.

Inclusion Criteria:

Eligible patients must be at least 18 years of age with a diagnosis of
NSCLC that has gotten worse during or after treatment with platinum-based chemotherapy.
Patients must have at least one tumor that can be evaluated by the doctor during the
investigational drug treatment. Any side-effects from prior chemotherapy must have
subsided, and blood and urine tests must show adequate bone marrow, liver, and kidney

Exclusion Criteria: Any of the following will exclude patients from study participation:
receipt of more than 1 prior regimen of chemotherapy for NSCLC (repeat of the same
chemotherapy at different points in time count as 1 regimen). Irradiation to 25% or more
of bone marrow, prior high dose chemotherapy with bone marrow or stem cell support,
current participation in other clinical trials, pregnant or breast-feeding women, known
HIV-positive or AIDS-related illness.

Type of Study:


Study Design:

Primary Purpose: Treatment


United States: Food and Drug Administration

Study ID:




Start Date:

Completion Date:

October 2002

Related Keywords:

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Pharmacia
  • Neoplasms
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms



Research Center Berkeley, California  94704
Research Center Chicago, Illinois  60637-1463
Research Center Louisville, Kentucky  40202
Research Center West Boylston, Massachusetts  01583
Research Center Ann Arbor, Michigan  48109
Research Center Lebanon, New Hampshire  03756
Research Center Nashville, Tennessee  37232-6868
Research Center Arlington, Texas  76012